CN1328849A - Medicine for curing cancers and its preparation method - Google Patents

Medicine for curing cancers and its preparation method Download PDF

Info

Publication number
CN1328849A
CN1328849A CN01129458A CN01129458A CN1328849A CN 1328849 A CN1328849 A CN 1328849A CN 01129458 A CN01129458 A CN 01129458A CN 01129458 A CN01129458 A CN 01129458A CN 1328849 A CN1328849 A CN 1328849A
Authority
CN
China
Prior art keywords
radix
herba
milliliters
medicine
shallow oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN01129458A
Other languages
Chinese (zh)
Other versions
CN1150928C (en
Inventor
焦成玉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011294582A priority Critical patent/CN1150928C/en
Publication of CN1328849A publication Critical patent/CN1328849A/en
Application granted granted Critical
Publication of CN1150928C publication Critical patent/CN1150928C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses a medicine for curing cancers and its preparation method. The said invention is an oral liquor made up from pure Chinese medicinal materials, including 35 Chinese medicinal materials of codonopsis root, astragalus root, avate atractylodes root, poria, unripe bitter orange, saussurea root and others through the process of removing impurity, decocting, concentrating, sterilizing and bottling. Its therapeutic effect is obvious and reliable, and it is convenient for taking in.

Description

A kind of curing cancer drug and preparation method thereof
The present invention relates to a kind of medicine of controlling cancer, more particularly, the present invention relates to a kind of is the oral liquid and preparation method thereof of feedstock production with the Chinese herbal medicine.
Cancer is a serious harm human body health, threatens human life's first killer.The World Health Organization's statistics in 1970, in the whole world 4,000,000,000 populations, have about five hundred ten thousand because of malignant tumor death person every year.This tissue statistics in 1981 shows that about 37,000,000 cancer patients are arranged at present in the world; The new patient of developing country's annual increase by 5,000,000 cancers; Annual increase by the 3000000 new cancer patients of developed country.Cancer is considered to cause in the world at present three big one of the main reasons of people's death, therefore seeks new cancer therapy drug, has become the emphasis of current medical science and life science.
At present, generally use the treatment method for cancer to be chemotherapy and radiation both at home and abroad, and hemopoietic system, the immunologic function of chemotherapy, radiotherapy meeting major injury human body, and side effect is many, toxic reaction.
The object of the present invention is to provide a kind of determined curative effect, easy to use, safety non-toxic, what can effectively treat cancer is oral liquid of raw material and preparation method thereof with the Chinese herbal medicine.
Technical scheme of the present invention is to select Chinese crude drug meticulously, and rational formula is prepared into oral liquid.
Medicine of the present invention is made by following component: (unit: gram)
Radix Codonopsis 5-30 Radix Astragali 5-60 Rhizoma Atractylodis Macrocephalae 5-15 Poria 5-30
Only real 3-20 Radix Aucklandiae 5-20 Endothelium corneum 5-20 Fructus Akebiae 5-10
Radix Notoginseng 2-10 Radix Clematidis 5-20 Rhizoma Curcumae 3-10 Rhizoma Smilacis Chinensis 5-20
Half time 3-10 Rhizoma Arisaematis of Radix Ranunculi Ternati 3-20 Chinese 3-10 Bulbus Fritillariae Uninbracteatae 5-20
Herba Hedyotidis Diffusae 5-30 Herba Portulacae Grandiflorae 5-30 Flos Lonicerae 5-90 Radix Scutellariae 5-20
Fructus Forsythiae 5-30 Radix Sophorae Tonkinensis 5-20 Herba Selaginellae Doederleinii 5-20 Scolopendra 1-6
Scorpio 10-20 Pseudobulbus cremastrae seu pleiones 5-20 Herba Solani Nigri 10-30 Herba Solani Lyrati 5-20
Herba Euphorbiae Helioscopiae 5-10 Herba Duchesneae Indicae 5-20 Cutis Bufonis 2-6 Herba Crotalariae sessiliflorae 5-30
Gekko Swinhonis 2-10 Calculus Bovis 3-10 Radix Glycyrrhizae 5-20
Above-mentioned curing cancer drug is a kind of oral liquid, and its preparation method is as follows:
(1) selects and differentiates Chinese crude drug;
(2) remove clean impurity and dust;
(3) earlier with 2000 milliliters in cold water with Chinese medicine bubble two hours, with marmite or boiling machine
Boil medicine, drench 500 milliliters after the half an hour of boiling, add boiled water and fry in shallow oil for 1000 milliliters
Drench 500 milliliters after half an hour, add 500 milliliters in boiled water again and fry in shallow oil pouring half an hour
Go out;
(4) fry in shallow oil and be concentrated into 750 milliliters of bottlings frying in shallow oil the herb liquid that drenches for three times;
(5) standby behind the autoclaving.
Curing cancer drug principle of the present invention is that strengthening the body resistance, blood circulation promoting and blood stasis dispelling, resolving phlegm and softening hard masses, regulating to soothe the middle-JIAO, heat-clearing and toxic substances removing, treating the poisonous disease with poisonous drugs, group attack heresy and just do not hinder.Wherein, Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Fu Ling are that strengthening the body resistance is main, improve patient's immunologic function and press down cancer growth effect obvious.Radix Codonopsis, the Radix Astragali, QI invigorating, blood circulation depending on qi flow.Mend the void of patient's whole body, exempt from the misgivings of positive extreme exhaustion of QI.The Rhizoma Atractylodis Macrocephalae, the invigorating the spleen and benefiting QI of volt Siberian cocklebur; dampness helps fortuneization; the transdifferentation of energy invigorating the spleen and regulating the stomach antitumor; four monarchs drug are instrumental ensembled trouble void can be mended, and improve lotus tumor human autoimmune function, make cancerous cell be tending towards the change of normalization; the T cell is raise; T suppresses cell-stimulating and now exempts from also to be had anti-startup, the function of anti-sudden change by antagonism.The Radix Aucklandiae, only reality, Fructus Akebiae, Endothelium corneum circulation of qi promoting are pleasant, and row is long-pending broken real, and dissipating depression of QI looses and stagnates, gather to hinder network and must disappear, and the relieving distension of being good for the stomach again, polyphagia can increase the matter of the day after tomorrow, and the stasis stasis of blood is gone and the cancer heresy can not be stayed.Calculus Bovis, Fu Ling, the Chinese half time, Rhizoma Arisaematis, Bulbus Fritillariae Uninbracteatae resolving phlegm and softening hard masses eliminating stagnation are removed the turbid base of expectorant knot, and the keying of having one's ideas straightened out can make the tumor body change softening dwindling.Radix Notoginseng, Radix Clematidis, Rhizoma Smilacis Chinensis, Rhizoma Curcumae, the Radix Ranunculi Ternati diffusing blood stasis of invigorating blood circulation, its major function promotes the proliferation and differentiation of T cell, strengthens the vigor of NK cell TK cell, and can induce IFN-and β cell growth factor to generate.Flos Lonicerae Radix Scutellariae, Fructus Forsythiae, Herba Hedyotidis Diffusae, Herba Portulacae Grandiflorae, Herba Crotalariae sessiliflorae, Radix Sophorae Tonkinensis, Herba Selaginellae Doederleinii are heat-clearing and toxic substances removing disappearance medicine, and malignant growth is skin ulcer in vivo, and this eight flavors medicine is skin ulcer section first panacea.The broad-spectrum antiseptic heat and toxic materials clearing away medicine can be changed living dysplasia, and cancerous protuberance must disappear not have and deposit.Scorpio, Scolopendra, Gekko Swinhonis, Pseudobulbus cremastrae seu pleiones, imperial Cai, Herba Euphorbiae Helioscopiae Herba Solani Lyrati, Herba Duchesneae Indicae, dry maxima skin are the principal agent of toxicity treating the poisonous disease with poisonous drugs, the poison heresy be disease, must destroy the own adjusting attitude of human body, its broken equal property is detected in the part of pathological changes in the early stage, but malicious heresy is not removed, with the passing of time can cross positive and negative, the regulating networks of length that multi-level multipath destroys human body, execute the notes high concentration to tumor in a large number for a long time and kill the cancer poison, there is no the whole body toxicity, and tissue intersolubility is good, poison stasis of blood in bulk accumulates poison and becomes carbuncle, group's poison tiger and attack it.Improved cytophagous phagocytic function, improved the NK cell cancerous cell again, whatsoever the cancerous cell of sample all can make the softening disappearance of its atrophy.
Use medicine of the present invention can bring into play the Synergistic anti-cancer effect of medicine, do not perform the operation not that chemotherapy also can obtain ideal curative effect, cured the over one hundred people of cancer patient.Effective percentage is 100%, and recovery rate reaches 90%.
Medical record 1
Grandson * *, the woman, 69 years old, Peng Ji township, county Ma Liuze people from village conquered east in the Shandong Province.The patient has two more than ten years of gastric ulcer, arthritis, in recent years hypertension, heart disease again.In May, 1996 is because of the severity of having a stomachache, ineffective with the stomachache medicine, and look into shellfish meal to Liaocheng Prefecture hospital, gastroscope CT examines and is three of cardiac cancer commentaries on classics hepatocarcinoma, go through to Jinan in spite of illness again and Wan Jie tumour hospital all can't perform the operation, have to be with regard to Chinese traditional treatment, the people's yellowish complexion of diagnosing a disease surplus quarter, painful looks, the stringy and thready pulse red tongue, tongue is later half strips off, after 60 doses of the oral liquids of clothes from not tearing stomach open also not bitterly, but stomach is also received the tongue fur area that comes off and is reduced by half, and obeys 100 pairs of Chinese medicines, looks into lump in March, 97 at the CT of Shenxian County hospital and dwindles half, the reuse oral liquid is interrupted to be taken, looking into CT report tumor in the Shenxian County in 98 years and only stay calcification point, examine mistake before hospital is suspected, fully recovers in Liaocheng report review in the back.Annual later on interval is taken the twenty or thirty agent and is dealt with problems arising from an accident, and patient is still alive when visiting so far.
Medical record 2
Yellow * *, the man, 26 years old, Donga, Shandong Province county Liu collected the village people, and junior college graduation back is in the newspaper office's advertisement center working of Liaocheng day.Because of chest pain uncomfortable in chest at Liaocheng Prefecture hospital CT find when just having graduated in July, 98, and thoracic cavity lymph cancerous protuberance is listened the ward mate to introduce when hospital's chemotherapy and changeed the here Chinese traditional treatment, and patient can't bear to stand the hardship of chemotherapy, in addition Ang Gui medical care expenses.Fatigue and lack of strength when examining has nipple behind the deep-thready pulse thick fur, and the right upper extremity nest has 2 * 2 millimeters lymphs nuclear, chest pain, and unhappy cough, low grade fever, to 60 doses of Chinese medicine oral liquid clothes, above-mentioned symptom is eliminated substantially, oneself is willing to take traditional Chinese medicine more, and interruption is taken.Eliminate at the regional CT of institute check thoracic cavity lymph lump in October, 98, and the back was eaten five doses in every month, and all drug withdrawals are so far visited good.
Medical record 3
Zhu * *, man, 68 years old, ancient city township, Shenxian County, Shandong Province Zhu Lou people from village.Patient on March 3rd, 2000 in the Liaocheng Prefecture special institute make gastroscope and draw in the net biopsy and make a definite diagnosis the stomach bottom lump and relate to cardia, pathology is middle differentiation cancer.Because of the household can not afford hospital expenses less, come here treatment, patient not to know it oneself is what disease, but meet yellow thready pulse, indigestion and loss of appetitely eat that steamed bun difficulty, body are unable, backache, stomach upset do not see lymph metastasis, give Chinese medicine oral liquid, the January disease of taking medicine alleviates, and the clothes that continue are special good, patient asks whether can not take medicine before the Spring Festival, I give repeated exhortations to advise to be interrupted after the Spring Festival and take medicine, can not full cut-off, now visit good, the busy housework of energy is called on relatives.

Claims (2)

1, a kind of curing cancer drug is characterized in that it is the medicament made from the raw material of following prescription: (unit: gram)
Radix Codonopsis 5-30 Radix Astragali 5-60 Rhizoma Atractylodis Macrocephalae 5-15 Poria 5-30
Only real 3-20 Radix Aucklandiae 5-20 Endothelium corneum 5-20 Fructus Akebiae 5-10
Radix Notoginseng 2-10 Radix Clematidis 5-20 Rhizoma Curcumae 3-10 Rhizoma Smilacis Chinensis 5-20
Half time 3-10 Rhizoma Arisaematis of Radix Ranunculi Ternati 3-20 Chinese 3-10 Bulbus Fritillariae Uninbracteatae 5-20
Herba Hedyotidis Diffusae 5-30 Herba Portulacae Grandiflorae 5-30 Flos Lonicerae 5-90 Radix Scutellariae 5-20
Fructus Forsythiae 5-30 Radix Sophorae Tonkinensis 5-20 Herba Selaginellae Doederleinii 5-20 Scolopendra 1-6
Scorpio 10-20 Pseudobulbus cremastrae seu pleiones 5-20 Herba Solani Nigri 10-30 Herba Solani Lyrati 5-20
Herba Euphorbiae Helioscopiae 5-10 Herba Duchesneae Indicae 5-20 Cutis Bufonis 2-6 Herba Crotalariae sessiliflorae 5-30
Gekko Swinhonis 2-10 Calculus Bovis 3-10 Radix Glycyrrhizae 5-20
2, curing cancer drug according to claim 1 is characterized in that described curing cancer drug is a kind of oral liquid, and its preparation method is as follows:
(1) selects and differentiates Chinese crude drug;
(2) remove clean impurity and dust;
(3) earlier with 2000 milliliters in cold water with Chinese medicine bubble two hours, boil medicine with marmite or boiling machine, drench 500 milliliters after the half an hour of boiling, add and drench 500 milliliters after 1000 milliliters in boiled water is fried in shallow oil half an hour, add boiled water again and fry in shallow oil for 500 milliliters and drench half an hour;
(4) fry in shallow oil and be concentrated into 750 milliliters of bottlings frying in shallow oil the herb liquid that drenches for three times;
(5) standby behind the autoclaving.
CNB011294582A 2001-06-21 2001-06-21 Medicine for curing cancers and its preparation method Expired - Fee Related CN1150928C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011294582A CN1150928C (en) 2001-06-21 2001-06-21 Medicine for curing cancers and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011294582A CN1150928C (en) 2001-06-21 2001-06-21 Medicine for curing cancers and its preparation method

Publications (2)

Publication Number Publication Date
CN1328849A true CN1328849A (en) 2002-01-02
CN1150928C CN1150928C (en) 2004-05-26

Family

ID=4669191

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011294582A Expired - Fee Related CN1150928C (en) 2001-06-21 2001-06-21 Medicine for curing cancers and its preparation method

Country Status (1)

Country Link
CN (1) CN1150928C (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299745C (en) * 2004-05-18 2007-02-14 张明生 Medicament composition for treating tumour
CN1313107C (en) * 2005-06-29 2007-05-02 马宝瑜 Medicine for treating tumor
CN1314409C (en) * 2005-01-05 2007-05-09 谢志明 Medicine for inhibiting and eliminating cancer
CN100391515C (en) * 2002-11-21 2008-06-04 杜仰恩 Chinese patent medicine for treating primary lung cancer
CN102008685A (en) * 2010-11-23 2011-04-13 高学哲 Chinese medicinal powder for treating liver cancer, lung cancer and pancreatic cancer
CN102362967A (en) * 2011-08-19 2012-02-29 马正华 Chinese herbal medicine for treating lung cancer
CN102872427A (en) * 2012-10-30 2013-01-16 陈海林 Medicinal preparation for treating esophagus cancer
CN103705853A (en) * 2013-12-28 2014-04-09 李清元 Cancer-eliminating and stasis-dissolving pill
CN105796733A (en) * 2016-04-18 2016-07-27 张瑞武 Traditional Chinese medicine composition for preventing cancers and preparation method thereof
CN115105576A (en) * 2022-06-14 2022-09-27 中国中医科学院广安门医院 Traditional Chinese medicine composition for treating ovarian cancer and traditional Chinese medicine preparation and application thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100400088C (en) * 2004-05-28 2008-07-09 张海峰 Anticancer medicine
CN102526283A (en) * 2011-11-02 2012-07-04 宁波海逸生物科技有限公司 Health-care medicine formula with functions of enhancing immunity, alleviating physical fatigue and resisting tumor
CN102600362B (en) * 2012-02-02 2014-01-08 焦成玉 Traditional Chinese medicine oral liquid for treating leukemia and preparation method thereof

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100391515C (en) * 2002-11-21 2008-06-04 杜仰恩 Chinese patent medicine for treating primary lung cancer
CN1299745C (en) * 2004-05-18 2007-02-14 张明生 Medicament composition for treating tumour
CN1314409C (en) * 2005-01-05 2007-05-09 谢志明 Medicine for inhibiting and eliminating cancer
CN1313107C (en) * 2005-06-29 2007-05-02 马宝瑜 Medicine for treating tumor
CN102008685A (en) * 2010-11-23 2011-04-13 高学哲 Chinese medicinal powder for treating liver cancer, lung cancer and pancreatic cancer
CN102008685B (en) * 2010-11-23 2012-07-04 高学哲 Chinese medicinal powder for treating liver cancer, lung cancer and pancreatic cancer
CN102362967A (en) * 2011-08-19 2012-02-29 马正华 Chinese herbal medicine for treating lung cancer
CN102872427A (en) * 2012-10-30 2013-01-16 陈海林 Medicinal preparation for treating esophagus cancer
CN103705853A (en) * 2013-12-28 2014-04-09 李清元 Cancer-eliminating and stasis-dissolving pill
CN105796733A (en) * 2016-04-18 2016-07-27 张瑞武 Traditional Chinese medicine composition for preventing cancers and preparation method thereof
CN115105576A (en) * 2022-06-14 2022-09-27 中国中医科学院广安门医院 Traditional Chinese medicine composition for treating ovarian cancer and traditional Chinese medicine preparation and application thereof
CN115105576B (en) * 2022-06-14 2023-06-23 中国中医科学院广安门医院 Traditional Chinese medicine composition for treating ovarian cancer, traditional Chinese medicine preparation and application thereof

Also Published As

Publication number Publication date
CN1150928C (en) 2004-05-26

Similar Documents

Publication Publication Date Title
CN101274087B (en) Chinese medicine decoction for invigorating gallbladder and removing gall-stone
CN102078510B (en) Chinese medicinal composition for treating coronary heart disease
CN1150928C (en) Medicine for curing cancers and its preparation method
CN1475229A (en) Antifatigue compound Chinese medicine prescription and its preparation method
CN103933468A (en) Traditional Chinese medicine for treating acute pancreatitis
CN105056124A (en) Medicine for treating hypertension and diabetes
CN102210820A (en) Chinese medicinal composition for treating leukemia
CN103736018A (en) Medicine for treating gallstones and preparation method thereof
CN104043050A (en) Traditional Chinese medicine composition for treating cholecystitis
CN102274463A (en) Traditional Chinese medicine capsule for treating breast cancer
CN103272176B (en) Traditional Chinese medicine composition for treating cardiovascular disease and preparation method thereof
CN105796789A (en) Traditional Chinese medicine preparation for treating coronary heart disease
CN102125621B (en) Traditional Chinese medicine preparation for treating senile constipation
CN1101199C (en) Chinese-medicinal capsule for treating hyperlipomia
CN105106758A (en) Traditional Chinese medicine composition for treating phlegm and blood stasis type dizziness
CN105477330A (en) Traditional Chinese medicine composition for treating arrhythmia
CN101502597B (en) Medicament for treating stomachache and preparation method thereof
CN101721518A (en) Traditional Chinese medicine for treating senile constipation
CN1294961C (en) Oral liquid for curing myocardial ischemia and process for preparing the same
CN1055235C (en) Oral liquor for treatment of lung cancer and preparation method therefor
CN1062172C (en) Medicine for treating cervical spondylopathy
CN101584839A (en) Chinese medicament for treating acute and chronic cholecystitis
CN1994415B (en) Orally administered Chinese medicine for treating dysmenorrhea
CN1056308C (en) Medicine for adjusting cranial nerve function
CN105148050A (en) Traditional Chinese medicinal composition for treating kidney stone

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040526

Termination date: 20100621